Founder and CEO of US online social media and social networking service Facebook Mark Zuckerberg. Photo by KENZO TRIBOUILLARD/AFP via Getty Images/FILE)
Mark Zuckerberg and his wife Priscilla Chan have donated $25 million through their foundation to a philanthropic effort organized by Bill Gates to explore new coronavirus treatments.
The Gates Foundation donated $50 million last week to what it’s calling the “COVID-19 Therapeutics Accelerator.” The initiative brings together life sciences companies to collaborate on the development of new vaccines, diagnostics, and treatments for COVID-19.
“The Therapeutics Accelerator will enable researchers to quickly determine whether or not existing drugs have a potential benefit against COVID-19,” Chan and Zuckerberg said in a press release. “We hope these coordinated efforts will help stop the spread of COVID-19 as well as provide shared, reusable strategies to respond to future pandemics.”
The two donations are the largest from tech billionaires since the coronavirus outbreak. Wellcome and Mastercard are supporting the effort as well.
The goal of the initiative is to either develop a new drug or adapt an existing treatment that it could help distribute alongside partnering pharmaceutical companies.
The 15 companies participating in the project kicked off the effort by sharing their proprietary libraries of molecular compounds that have some history of being tested with COVID-19.
The lineup includes big names in biotech such as Johnson & Johnson, Merck, Pfizer, Sanofi, and Bristol-Myers Squibb.
Makena Kelly, politics reporter at The Verge, joins Cheddar News to discuss what's next for net neutrality as Biden's other nominee for the FCC, Gigi Sohn, awaits votes from the committee and Senate.
Specializing in AI, robotics, and automation for the global supply chain, Symbotic announced last month it will be tapping the public markets in a SPAC deal with investment giant SoftBank. Symbotic CFO Tom Ernst and Vikas Parekh, a managing partner at SoftBank Investment Advisers spoke with Cheddar about going public and the future of modernizing logistics amid the constrained supply networks. "The supply chain is fundamentally broken," said Ernst. "By employing the best in modern technology for autonomous vehicles and artificial intelligence, we're able to fundamentally rethink the way in which you receive and store and sort goods, making for a dramatically more efficient supply chain."
Michael Hershfield, Founder & CEO of Accrue Savings, joined Wake Up With Cheddar to discuss the company's new round of funding, and its core mission of rewarding consumers for saving rather than taking on more debt with buy now, pay later options.
Markets opened higher on the first trading day of the new year as investors continue to watch inflation and the rapid spread of the omicron variant in the U.S. Frances Newton Stacy, Optimal Capital Dir. of Strategy/Market Analyst joined Cheddar's Opening Bell to discuss.
Markets opened higher as investors react to positive data on the labor front, with weekly jobless claims falling to 198,000 for the week ending December 25. Ross Mayfield, investment strategy analyst at Baird joined Cheddar's Opening Bell to discuss the market open.
Sky Harbour, a company developing private aviation infrastructure, is gearing up to land on Wall Street. The company announced plans to go public through a SPAC deal with Yellowstone Acquisition Company, valuing the combined venture at $777 million. The company will trade on the New York Stock Exchange as $SKYH.
Dish Network is reportedly in discussions to merge with DirecTV. According to the NY Post, the two sides are currently 'trying to iron out the details.' The competitors have had talks in the past -- over the course of the past 20 years, but those talks been halted by the DOJ over antitrust concerns. Lydia Moynihan, Business Reporter, NY Post joined Cheddar's Opening Bell to discuss.
